Abstract: An electronic system with an electronically controlled electronic locking mechanism is provided. The system includes a first electronic device having a first part, a first fastening element, a second part, and an electronic locking element. The first fastening element is pivotally connected to the first part and rotates relatively to the first part. The second part includes a fastening portion. The electronic locking element is disposed at the first part, electronically connected to the first electronic device, and connected to the first fastening element. When the fastening portion of the second part contacts and fastens to the first fastening element of the first part, the first electronic device supplies power to the electronic locking element, and thus the electronic locking element fixes the first fastening element to lock the first part and the second part together.

Abstract: An electronic system with an electronically electronic locking element is provided. The system includes a first electronic device having a first part, a first fastening element, a second part, and an electronic locking element. The first fastening element is pivotally connected to the first part and rotates relatively to the first part. The second part includes a fastening portion. The electronic locking element is disposed at the first part, electronically connected to the first electronic device, and connected to the first fastening element. When the fastening portion of the second part contacts and fastens to the first fastening element of the first part, the first electronic device supplies power to the electronic locking element, and thus the electronic locking element fixes the first fastening element to lock the first part and the second part together.

Abstract: The present invention relates to a composition comprising compounds of formula (I-V), the pharmaceutically-acceptable carrier, solvent, or the salts thereof which is used to treat autophagy-associated diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, etc. The present invention also relates to a method of treating these diseases by administering a therapeutically-effective amount of the compound to the subject in need of the treatment. The present invention further relates to the use of this compound in preparation of the composition to treat the diseases.